We are currently enrolling patients in a research study about biomarkers in Huntington’s disease. The purpose of the study is to identify small molecules that can be measured in the blood and spinal fluid in order to determine the stage and severity of Huntington’s disease and whether or not a person has Huntington’s disease. Your participation in the study would involve 3-4 visits over 18-19 months.

You may participate in this study if you have Huntington’s disease or as a healthy volunteer.

You may qualify for this study if:

• You are ages 20-80 years old
• You do not have any other progressive neurological conditions
• If you have HD, you have had genetic testing for the disease that causes Huntington’s disease